Erythromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis
Anant Labs manufacture and furnish high quality Erythromycin impurities for global markets. Our Erythromycin EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
erythromycin114-07-8Erythromycin AE-MycinAbomacetinIlotycinEmgelErymaxEritromicinaErythromycineErythromycinumRobimycinTorlamicinaErydermErythromycin baseErycetteErythrogranErygelSansacErythro-StatinErythra-DermAkne-MycinERYCE-GladesEry-TabE-BaseErythroguentDotycinStiemycinR-P MycinEryc SprinklesE-Solve 2Erythromast 36T-StatC-Solve-2Eryc 125erythromycin-AOftalmolosa Cusi EritromicinaStaticinRetcinDTXSID4022991J01FA01NSC-55929PCE (ERYTHROMYCIN)63937KV33DDTXCID102991CHEBI:42355NSC55929(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione7540-22-9KerymaxSpotexErymax sprinkleAknemycin plusTStatEryacne 2Eryacne 4Gallimycin-36T Stat(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dioneErythro 200Lactate, ErythromycinRommix 250 ecRommix 500 ecPhosphate, ErythromycinRefChem:6427Erythro-100 InjectionAPI E.M. ErythromycinErythromycin Base FilmtabErythro-36, Erythro-DryAPI E.M ERYTHROMYCINCHEBI:48923erythromycin topical solution 2%Gallimycin Injection, Gallimycin-100(2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3,4,6-Trideoxy-3-dimethylamino-beta-D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxopentadecan-13-olide204-040-1616-217-43''-O-DemethylerythromycinRP-MycinEryacneErythrocinPantomicinaMFCD00084654A/T/SerythroErmycinErycenAkninTheramycin ZAk-MycinErytabIndermBenzamycinCHEMBL532DumotrycinMephamycinWemid(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dioneErythromycin C-13EndoeritrinEritomicinaErythrodermErytrociclinPharyngocinProterytrinAcneryneAcnesolAknemycinC37H67NO13DerimerDeripilErisoneEryacnenErydermerEryhexalErysafeIloticinaLatotrydLederpaxMercinaOftamoletsPantodermPantodrinRomycinStiemicynTiprocinEmuvinEmycinErecinErymedErytopAustriaSErosEry-maxinErythro-TevaSans-acneErimycin-TEry-DiolanInderm GelDel-MycinAknederm Ery GelUdima Ery Gelcyclotetradecane-2,10-dioneEmu-Ve8HPH7ND0LNSkid Gel E(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dioneAkne Cordes LosungERYIlosone (estolate)Ilotycin T.S.E-Mycin (base)Ery-Tab (base)Emu-VEry-BE-Base (base)ERYC (base)N-Methylerythromycin APCE Dispertab (base)Eryc-125Eryc-250Eritromicina [INN-Spanish]Erythromycine [INN-French]Erythromycinum [INN-Latin]Erythromycin, labeled with carbon-13Staticin (TN)(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dioneAkne-mycin (TN)Erygel (TN)Eryc (TN)T-stat (TN)Pce (TN)SR-05000001618Sentry AQ mardel maracynErythromycin & VRC3375erthromycintrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxaCCRIS 9078Erythromycin RS82343-12-2UNII-63937KV33DHSDB 3074NCGC00094670-01Erythromycin [USP:INN:BAN:JAN](3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethylte(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dioneCAS-114-07-8Prestwick_205EINECS 204-040-1Erythromycin A CRSNSC 55929215031-94-0Spectrum_000115Spectrum_000659Erythromycin (Standard)AI3-50138EM-APrestwick3_000151Spectrum2_000759Spectrum2_001263Spectrum4_000538Spectrum5_001596UNII-8HPH7ND0LNERYTHROMYCIN [MI]E0751ERYTHROMYCIN [INN]ERYTHROMYCIN [JAN]EC 204-040-1ERYTHROMYCIN [HSDB]SCHEMBL2601ERYTHROMYCIN [VANDF]BSPBio_000282BSPBio_002480ERYTHROMYCIN [MART.]KBioGR_001175KBioSS_000555KBioSS_001139MLS001066618BIDD:GT0017DivK1c_000294DivK1c_000397DivK1c_000702ERYTHROMYCIN [USP-RS]ERYTHROMYCIN [WHO-DD]ERYTHROMYCIN [WHO-IP]SPECTRUM1500280SPBio_000778SPBio_001226Erythromycin (mixture A,B,C)BPBio1_000312GTPL1456orb1309999orb3025580Erythromycin (JP18/USP/INN)HMS500O16KBio1_000294KBio1_000397KBio1_000702KBio2_000555KBio2_001139KBio2_003123KBio2_003707KBio2_005691KBio2_006275ERYTHROMYCIN [GREEN BOOK]MSK7801NINDS_000294NINDS_000397NINDS_000702ERYTHROMYCIN [ORANGE BOOK]HMS1920M04HMS2091D05HMS2095O04HMS3712O04Pharmakon1600-01500280ERYTHROMYCIN [EP MONOGRAPH]HY-B0220RKL10096ERYTHROMYCIN [USP MONOGRAPH]Tox21_111311Tox21_111869Tox21_300515BDBM50344942CCG-38992LMPK04000006MSK7801-100AMSK7801-100MNSC756759ERYTHROMYCINUM [WHO-IP LATIN]AKOS015895249MSK7801-1000AMSK7801-1000MAE22796DB00199Erythromycin for system suitability CRSNSC-756759BENZAMYCIN COMPONENT ERYTHROMYCINIDI1_000294IDI1_000397IDI1_000702SMP1_000119NCGC00179619-01NCGC00179619-02NCGC00179619-03NCGC00179619-18NCGC00254234-01AC-12744AC-12901SMR000544946SY070227Erythromycin for microbiological assay CRSErythromycin, potency: >=850 mug per mgErythromycin, tested according to Ph.Eur.SBI-0051368.P003Erythromycin, N-demethyl-N-(methyl-11C)-E6994Erythromycin 1000 microg/mL in AcetonitrileErythromycin Solution in Methanol, 100ug/mLNS00000203Third international Standard for ErythromycinErythromycin for impurity M identification CRSErythromycin Solution in Methanol, 1000ug/mLErythromycin, meets USP testing specificationsC01912D00140E-3250AB00051981_09AB00051981_10Erythromycin Solution in Acetonitrile, 100ug/mLErythromycin, Biotechnology Performance CertifiedErythromycin estolate impurity, free erythromycin-Erythromycin Solution in Acetonitrile, 1000ug/mLQ213511SR-01000799155Erythromycin, Antibiotic for Culture Media Use OnlyErythromycin, BioReagent, suitable for cell cultureSR-01000799155-2SR-05000001618-1SR-05000001618-2BRD-K63550407-001-12-7BRD-K63550407-001-13-5BRD-K63550407-028-03-9BRD-K63550407-028-04-7Z2587996953Erythromycin (mixture of A,B,C) 100 |Ig/mL in AcetonitrileErythromycin A, European Pharmacopoeia (EP) Reference StandardRoxithromycin EP Impurity A; Erythromycin;Erythromycin A(USP)Erythromycin, United States Pharmacopeia (USP) Reference StandardERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY]ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY]Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference StandardErythromycin, Pharmaceutical Secondary Standard; Certified Reference Material(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-|A-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-|A-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dioneErythromycin A; Dotycin; Erycin; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
